Skip to main content
. 2012 Sep 27;7(9):e46113. doi: 10.1371/journal.pone.0046113

Table 3. Association analysis of SNPs in TNF, LTA, TNFRSF1A and TNFRSF1B between case and control groups.

Gene Healthy Sepsis Severe sepsis Allelic Comparison Genotypic Comparison
SNP controls patients patients P1 adj OR1 adj 95% CI P2 adj OR2 adj 95% CI P1 adj P2 adj
TNF
rs1800629 0.00046 1.92 (1.26–2.92) 0.002 1.56 (1.23–2.76) 0.003 0.004
GG 560 (93.3%) 352 (93.9%) 369 (86.4%)
GA 38 (6.3%) 23 (6.1%) 56 (13.1%)
AA 2 (0.3%) 0 (0%) 2 (0.47%)
G 1158 (96.5%) 727 (96.9%) 794 (93%)
A 42 (3.5%) 23 (3.1%) 60 (7%)
rs361525 0.22 1.09 (0.98–1.87) 0.88 1.02 (0.84–1.42) 0.21 0.89
CC 550 (92%) 333 (88.8%) 382 (89.3%)
CT 48 (8%) 42 (11.2%) 46 (10.7%)
C 1148 (96%) 708 (94.4%) 810 (94.6%)
T 48 (4%) 42 (5.6%) 46 (5.4%)
rs1799724 0.21 1.18 (0.98–2.01) 0.52 1.06 (0.86–1.46) 0.12 0.85
GG 444 (73.6%) 263 (70.3%) 285 (67.9%)
GA 149 (24.7%) 107 (28.6%) 130 (31%)
AA 10 (1.7%) 4 (1.1%) 5 (1.2%)
G 1037 (86%) 633 (84.6%) 700 (83.3%)
A 169 (14%) 115 (15.4%) 140 (16.7%)
rs1799964 0.62 1.02 (0.92–1.42) 0.56 1.12 (0.84–1.46) 0.87 0.52
TT 384 (64.4%) 234 (62.2%) 265 (62.6%)
TC 188 (31.5%) 130 (34.6%) 140 (33.1%)
CC 24 (4%) 12 (3.2%) 18 (4.3%)
T 956 (80.2%) 598 (79.5%) 670 (79.2%)
C 236 (19.8%) 154 (20.5%) 176 (20.8%)
rs1800630 0.32 1.09 (0.81–1.40) 0.38 1.18 (0.72–1.43) 0.12 0.42
CC 412 (69%) 262 (70.6%) 275 (66.3%)
AC 179 (30%) 102 (27.5%) 128 (30.8%)
AA 6 (1%) 7 (1.9%) 12 (2.9%)
C 1003 (84%) 626 (84.4%) 678 (81.7%)
A 191 (16%) 116 (15.6%) 152 (18.3%)
LTA
rs909253 0.18 0.89 (0.79–1.21) 0.36 0.82 (0.58–1.26) 0.29 0.14
AA 178 (29.7%) 103 (27.8%) 140 (33.6%)
AG 266 (44.4%) 181 (48.9%) 181 (43.5%)
GG 155 (25.9%) 86 (23.2%) 95 (22.8%)
A 622 (51.9%) 387 (52.3%) 461 (55.4%)
G 576 (48.1%) 353 (47.7%) 371 (44.6%)
TNFRSF1A
rs767455 0.16 1.20 (0.82–1.68) 0.72 1.04 (0.76–1.23) 0.27 0.76
AA 462 (76.4%) 276 (73.4%) 302 (71.4%)
GA 131 (21.7%) 90 (23.9%) 112 (26.5%)
GG 12 (2.0%) 10 (2.7%) 9 (2.1%)
A 1055 (87.2%) 642 (85.4%) 716 (84.6%)
G 155 (12.8%) 110 (14.6%) 130 (15.4%)
rs4149570 0.78 0.96 (0.67–1.09) 0.41 1.09 (0.82–1.34) 0.86 0.62
GG 178 (29.3%) 118 (31.6%) 123 (29.2%)
GT 303 (49.9%) 192 (51.3%) 212 (50.4%)
TT 126 (20.8%) 64 (17.1%) 86 (20.4%)
G 659 (54.3%) 428 (57.2%) 458 (54.4%)
T 555 (45.7%) 320 (42.8%) 384 (45.6%)
TNFRSF1B
rs1061622 0.32 0.92 (0.87–1.28) 0.32 1.02 (0.91–1.46) 0.35 0.38
TT 398 (65.9%) 262 (69.7%) 297 (70.5%)
TG 190 (31.5%) 102 (27.1%) 116 (27.6%)
GG 16 (2.6%) 12 (3.2%) 8 (1.9%)
T 986 (81.6%) 626 (83.2%) 710 (84.3%)
G 222 (18.4%) 126 (16.8%) 132 (15.7%)
rs3397 0.48 1.04 (0.92–1.41) 0.17 1.28 (0.94–1.68) 0.30 0.32
GG 255 (41.9%) 156 (41.8%) 158 (37.6%)
AG 304 (49.9%) 194 (52%) 232 (55.2%)
AA 50 (8.2%) 23 (6.2%) 30 (7.2%)
G 814 (66.8%) 506 (67.8%) 548 (65.2%)
A 404 (33.2%) 240 (32.2%) 292 (34.8%)

SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval. Padj and ORadj came from multivariate logistic regression. P1 adj and OR1 adj, healthy control group vs severe sepsis group. P2 adj and OR2 adj, sepsis group vs severe sepsis group. A P-value of <0.005 (0.05/10) was considered statistically significant after Bonferroni correction.